The authors of these studies suggested that the immunological benefits could be related to IGF-I deficiency, resulting in reduced cell replication, lower DNA damage, as well as decreased IGF binding protein, and insulin. The gene discussed is IGF1; the disease is hyperinsulinemic hypoglycemia, familial, 4.